FDA Seeks Input on Improving Access to Nonprescription Medications
Published Date: 12/2/2025
Notice
Summary
The FDA wants your ideas on how to make it easier for people to get nonprescription drugs, like over-the-counter medicines. They’re gathering feedback now to help plan a public meeting in 2026. If you have thoughts, send them by February 2, 2026—this could lead to faster, cheaper access for everyone!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
NDA pathway requires consumer-use studies
If you seek to market a nonprescription drug via a new drug application (NDA) under section 505, you must submit adequate tests and substantial evidence that the drug is safe and effective for self-use. FDA often requires consumer studies—such as label comprehension, self-selection, actual use, and human factors studies—and typically requires more data when less is known about nonprescription use.
Public input open — comments due Feb 2, 2026
The FDA is asking the public—drug developers, health care providers, and consumers—to send ideas on how to increase access to nonprescription (over-the-counter) drugs. You can submit electronic or written comments that must be received by February 2, 2026; FDA will use the feedback to plan a public meeting in calendar year 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in